Akbank T.A.S. (OTCMKTS:AKBTY – Get Free Report) was the recipient of a significant decline in short interest in November. As of November 15th, there was short interest totalling 100 shares, a decline of 99.0% from the October 31st total of 10,400 shares. Based on an average daily trading volume, of 50,900 shares, the short-interest ratio is presently 0.0 days.
Akbank T.A.S. Stock Performance
OTCMKTS:AKBTY opened at $3.37 on Thursday. Akbank T.A.S. has a twelve month low of $2.21 and a twelve month high of $4.46. The firm has a market capitalization of $8.76 billion, a price-to-earnings ratio of 2.45 and a beta of 0.75. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 0.73. The firm’s fifty day simple moving average is $3.18 and its 200 day simple moving average is $3.57.
Akbank T.A.S. (OTCMKTS:AKBTY – Get Free Report) last issued its earnings results on Thursday, October 24th. The company reported $0.10 earnings per share for the quarter. The company had revenue of $1.18 billion during the quarter.
About Akbank T.A.S.
Akbank T.A.S., together with its subsidiaries, provides various banking products and services in Turkey and internationally. It operates through Consumer Banking and Private Banking; Commercial Banking, Corporate Banking, and SME Banking; and Treasury, Other, and Unallovated segments. The company’s consumer banking services comprise deposit accounts, retail loans, commercial installment loans, credit cards, insurance products, and asset management services, as well as bank cards, investment funds trading, automatic payment, foreign currency trading, safe deposit box rental, cheques, money transfer, investment banking, and telephone and internet banking.
Featured Articles
- Five stocks we like better than Akbank T.A.S.
- Basic Materials Stocks Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Is WallStreetBets and What Stocks Are They Targeting?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Golden Cross Stocks: Pattern, Examples and Charts
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Akbank T.A.S. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akbank T.A.S. and related companies with MarketBeat.com's FREE daily email newsletter.